[ad_1]
A new study suggests that low-dose aspirin may help people avoid the worst symptoms and side effects of COVID-19, USA Today reports.
- The study – which comes from researchers at George Washington University – looked at data from 412 patients who attended hospital for COVID-19 from March through July in 2020.
- Almost 24% of patients took aspirin seven days or less before being admitted to hospital, or within 24 hours of admission, according to the study published in the journal Anesthesia and Analgesia.
- More than 40% of patients saw their symptoms improve compared to those who did not take any version of the drug, according to the study.
- “Aspirin may have protective effects on the lungs and reduce the need for mechanical ventilation, intensive care admissions and in-hospital mortality in COVID-19 hospital patients,” the report said.
But remember – the researchers said “a randomized controlled trial would be needed to establish a cause and effect relationship,” according to USA Today.
What about aspirin for the COVID-19 vaccine?
The Centers for Disease Control and Prevention said people should talk to their doctors about taking “ibuprofen, acetaminophen, aspirin, or antihistamine” if they experience constant pain or discomfort from the drug. vaccine.
[ad_2]
Source link